Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Japanese patients and physicians often disagree on the severity of Alopecia Areata and treatment satisfaction, needing better communication and treatments.

Some patients treated with peginterferon and ribavirin for chronic hepatitis C had mild to moderate skin reactions, but treatment did not need to be stopped.

Reinfection patients had more physical complications, while initial infection patients had more mental health issues.

Diabetic patients often have ingrown nails due to obesity, high blood pressure, past injuries, bad nail trimming, nail fungus, weak foot pulse, and weak knee reflex.

Targeted cancer therapies have a significant but lower risk of causing hair loss compared to chemotherapy.

Teriflunomide is effective and generally safe for treating relapsing-remitting multiple sclerosis.

COVID-19 doesn't make alopecia areata worse.

Ayurveda, using herbs like ginger, garlic, and turmeric, can reduce chemo-radiotherapy side effects in cancer patients.

Alopecia affects patients' quality of life, with younger patients and longer-lasting hair loss experiencing greater impact.

People with myotonic dystrophy type 1 have a higher chance of getting skin tumors, including melanoma.

Post-finasteride patients show changes in gut bacteria, possibly causing various symptoms.

Patients with lichen planopilaris have a higher risk of heart disease.

Alopecia areata patients have lower vitamin D and slightly lower copper levels, so these should be checked.

Some dermatology patients in Turkey use traditional medicine, with herbal remedies being most common, but these treatments can have mixed results and risks.

Cutaneous lupus patients have higher levels of certain immune cells in their blood and skin.

The document concludes that research on sulfatase inhibitors should continue due to their potential in treating various diseases, despite some clinical trial failures.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.

New resveratrol-related compounds show promise for treating various health issues but need more research for clinical use.

New androgen receptor modulators show promise for treating diseases like prostate cancer and muscle wasting.

The revised European Patent Convention may limit generic drug use, affecting healthcare professionals' treatment choices.

Cancer treatments often cause hair disorders, significantly affecting patients' quality of life, and better management methods are needed.

Endocrine therapies for cancer significantly increase the risk of hair loss.

Minoxidil controls blood pressure but may cause kidney damage and needs diuretics to prevent swelling.

Finasteride reduces gambling symptoms in Parkinson's patients.

Sublingual minoxidil effectively treats hair loss with mild side effects.

Oral bicalutamide is safe and effective for female hair loss.

Levodopa for Parkinson's disease might be linked to skin issues like melanoma, but it's unclear if the drug or the disease causes them.

More than half of patients who had acromegaly surgery experienced hair loss, with varying degrees of recovery.

Oral minoxidil is a reasonably safe alternative for patients allergic to the topical form.

Vaccination is crucial for psoriasis patients on immunosuppressive therapy to manage COVID-19 risks.